
Carbamazepine
Carbamazepine is a long-established first choice for focal seizures, with high-certainty trial evidence that it controls them about as well as the best alternatives, although lamotrigine is stopped less often. It is also used for trigeminal neuralgia and, as Equetro, for acute mania. Grapefruit can raise its level, St. John's wort is advised against with anti-seizure drugs, and long-term use is linked to lower vitamin D.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
People with focal or generalized tonic-clonic seizures, trigeminal neuralgia, or (Equetro) bipolar I mania, whose prescriber has chosen carbamazepine and can monitor blood tests
Common dosing range
Set by your prescriber, who starts low and raises it slowly. The Tegretol label's adult epilepsy start is 200 mg twice daily, usual maintenance 800 to 1,200 mg a day; for trigeminal neuralgia the start is 100 mg twice daily, maintenance usually 400 to 800 mg a day
When to expect effects
Seizure control builds as the dose is raised weekly; self-induced faster breakdown settles after 3 to 5 weeks. In mania trials, improvement separated from placebo from day 7 to week 2
Watch out for
Boxed warnings for serious, sometimes fatal skin reactions (with a genetic test, HLA-B*1502, before starting in people of Asian ancestry) and for rare aplastic anemia and agranulocytosis. Do not stop it suddenly. Long-term use is linked to lower vitamin D; ask your doctor whether to check your vitamin D level
What is it
Carbamazepine is a prescription anti-seizure medicine that has been used since the 1960s. It comes as tablets and an oral suspension (Tegretol), extended-release tablets (Tegretol-XR) and extended-release capsules (Carbatrol, Equetro), as well as generics. FDA labels approve it for focal (partial) seizures, generalized tonic-clonic (grand mal) seizures and mixed seizure patterns, and for the facial nerve pain of trigeminal neuralgia. One brand, Equetro, is also approved for manic or mixed episodes of bipolar I disorder. It does not control absence (petit mal) seizures.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
focal (partial) seizures Strong Evidence | Among the most effective first choices for seizure remission; more treatment failures than lamotrigine (HR 0.78 in SANAD) | Children and adults with newly diagnosed focal seizures | The dose is raised weekly; trials measured 12-month remission over several years |
acute manic or mixed episodes of bipolar I disorder (Equetro) Good Evidence | Moderate; responders 41.5% vs 22.4% with placebo in one trial | Adults with bipolar I disorder in a manic or mixed episode, treated by a prescriber | Improvement separated from placebo from day 7 to week 2 |
trigeminal neuralgia and other long-term nerve pain Limited Evidence | Better than placebo in small short trials; size uncertain | Adults with true trigeminal neuralgia whose prescriber recommends it | Trials lasted 4 weeks or less; the label raises the dose only as needed for freedom from pain |
focal (partial) seizures
- Effect
- Among the most effective first choices for seizure remission; more treatment failures than lamotrigine (HR 0.78 in SANAD)
- Best fit
- Children and adults with newly diagnosed focal seizures
- Time
- The dose is raised weekly; trials measured 12-month remission over several years
acute manic or mixed episodes of bipolar I disorder (Equetro)
- Effect
- Moderate; responders 41.5% vs 22.4% with placebo in one trial
- Best fit
- Adults with bipolar I disorder in a manic or mixed episode, treated by a prescriber
- Time
- Improvement separated from placebo from day 7 to week 2
trigeminal neuralgia and other long-term nerve pain
- Effect
- Better than placebo in small short trials; size uncertain
- Best fit
- Adults with true trigeminal neuralgia whose prescriber recommends it
- Time
- Trials lasted 4 weeks or less; the label raises the dose only as needed for freedom from pain
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
focal (partial) seizures
Disease adjunctIn the SANAD trial, 1,721 UK children and adults for whom carbamazepine was the standard choice were randomly assigned to carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate and followed for years. Carbamazepine was significantly better than gabapentin at reaching 12 months free of seizures (HR 0.75) and similar to the others, while lamotrigine was less likely than carbamazepine to need stopping or changing (treatment failure HR 0.78). A 2022 Cochrane network meta-analysis of individual data from 14,789 people in 39 trials rated the evidence high certainty and concluded that carbamazepine, lamotrigine and levetiracetam show the best profile for focal seizures, with lamotrigine having fewer treatment failures than carbamazepine. SANAD was not blinded, and these are comparisons between drugs, not against placebo.
Bottom line: Carbamazepine controls focal seizures as well as the best alternatives, though lamotrigine is stopped less often.
acute manic or mixed episodes of bipolar I disorder (Equetro)
Disease adjunctTwo double-blind, placebo-controlled 3-week trials tested extended-release carbamazepine capsules in adults with bipolar I disorder having manic or mixed episodes. In the first (204 patients), mania scores improved more than with placebo from week 2, and 41.5% versus 22.4% had at least a 50% drop in mania score; the mean final dose was about 756 mg a day. In the second (239 hospitalized patients), mania scores improved more than with placebo from day 7. In the second trial, dizziness (39.3%), sleepiness (30.3%) and nausea (23.8%) were more common with carbamazepine, and total cholesterol rose. Both trials were short and lost many participants before the end.
Bottom line: Equetro eased acute mania more than placebo within 1 to 2 weeks in two short trials.
trigeminal neuralgia and other long-term nerve pain
Disease adjunctA 2014 Cochrane review found 10 small trials (480 participants) of carbamazepine for trigeminal neuralgia, diabetic nerve pain and pain after stroke. Most were crossover trials lasting 4 weeks or less, and none met the review's standards for good-quality evidence. In this weak evidence, carbamazepine generally relieved pain better than placebo. Side effects were common: 65% had at least one with carbamazepine versus 27% with placebo, and rashes were linked to the drug. The reviewers concluded it is probably effective in some people, with caveats. Trigeminal neuralgia is an FDA-labeled use.
Bottom line: Carbamazepine probably eases trigeminal neuralgia, but the trials are small, short and old.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose and orders the blood tests; never stop or change it on your own.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: serious and sometimes fatal skin reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis), estimated at 1 to 6 per 10,000 new users in mainly white populations and about 10 times higher in some Asian countries. People with ancestry in at-risk populations should be tested for the HLA-B*1502 gene variant before starting. Over 90% of these reactions occur in the first few months.
Boxed warning: aplastic anemia and agranulocytosis (loss of blood-forming cells), 5 to 8 times more likely than in the general population but still rare. The label calls for baseline blood counts and close monitoring if counts fall.
DRESS (a multi-organ allergic reaction with fever, rash and swollen glands), anaphylaxis and angioedema, sometimes fatal.
Suicidal thoughts or behavior, a risk seen across anti-seizure drugs (about 1 extra case per 530 people treated in pooled trials).
Low blood sodium (hyponatremia), often from SIADH; the risk appears dose-related and is higher in older adults and people taking diuretics.
Liver injury, from mild enzyme rises to rare liver failure, and heart rhythm problems including AV heart block, mostly in people with existing ECG abnormalities.
More frequent seizures or status epilepticus if it is stopped suddenly.
Who should avoid it
- People with a history of bone marrow depression, or an allergy to carbamazepine or to tricyclic compounds such as amitriptyline, desipramine, imipramine or nortriptyline
- People taking nefazodone, or who took an MAOI antidepressant within the last 14 days
- People who test positive for HLA-B*1502, unless the benefit clearly outweighs the risk
- People with a history of hepatic porphyria, in whom acute attacks have been reported
Pregnancy & breastfeeding
Pregnancy: the label says carbamazepine can cause fetal harm. Use in pregnancy has been associated with birth defects, including spina bifida, and with developmental disorders. Uncontrolled seizures are also dangerous in pregnancy, and the label says not to stop anti-seizure medicine suddenly because of the risk of severe, life-threatening seizures; plan any change with your neurologist, and ask about the North American Antiepileptic Drug Pregnancy Registry. Carbamazepine can also make hormonal birth control less effective. Breastfeeding: carbamazepine and its active metabolite pass into breast milk. Most exposed infants have had no problems, but a few cases of hepatitis, vomiting and poor weight gain have been reported; decide with your prescriber how to feed your baby.
Interactions
The label lists nefazodone as a contraindication because carbamazepine drops nefazodone below effective levels, and says MAOI antidepressants should be stopped at least 14 days before starting carbamazepine. Your prescriber and pharmacist check for these.
Grapefruit blocks CYP3A4, the enzyme that breaks down carbamazepine. In 10 people with epilepsy already taking 200 mg three times daily, one dose with grapefruit juice instead of water raised the peak level from 6.55 to 9.20 mcg/mL and total exposure by about 40%, and the label lists grapefruit juice among things that raise carbamazepine levels. Talk to your doctor or pharmacist before having grapefruit, and report dizziness, drowsiness, unsteadiness or double vision.
Carbamazepine is an enzyme-inducing anti-seizure drug, a group long linked to lower vitamin D. A 2021 meta-analysis of 12 studies found people on carbamazepine averaged 21.8 ng/mL of 25-hydroxyvitamin D versus 28.0 ng/mL in people not taking it, regardless of age, sex or how long they had taken it. The label also lists low blood calcium and osteoporosis among reported effects. Ask your doctor whether to check your vitamin D level and bone health.
The UK medicines regulator advises people with epilepsy not to use St. John's wort with any anti-seizure medicine, because the herb changes liver enzymes that clear many of them, and after a reported case of more frequent, more severe seizures in a person taking other anti-seizure drugs. The effect on carbamazepine itself is less clear: in 8 healthy volunteers already on carbamazepine for 3 weeks, 14 days of St. John's wort did not change carbamazepine levels. Talk to your neurologist or pharmacist before starting or stopping it.
Carbamazepine lowers the hormone levels from birth control pills and implants, which can make them less effective; the label reports breakthrough bleeding and unintended pregnancies. Talk to your prescriber about a backup or alternative method.
Carbamazepine is expected to lower the levels of these blood thinners enough that they may not prevent clots, and the label says the combination should generally be avoided. If you take one, make sure both prescribers know.
Carbamazepine often causes dizziness and drowsiness, and the label advises caution with alcohol because of a possible additive sedative effect; its Medication Guide says not to drink until you talk to your healthcare provider. The Equetro label adds that alcohol and other CNS depressants can raise the risk of slowed breathing, profound sedation, low blood pressure and fainting with carbamazepine. The labels do not say alcohol changes carbamazepine levels or set a safe amount; ask your doctor before drinking, and do not drive until you know how the combination affects you.
In lab studies of human intestinal tissue, carbamazepine competitively blocked biotin uptake, and adults on long-term anti-seizure therapy excreted more biotin breakdown products and a marker of low biotin activity, suggesting faster biotin loss. These studies measured lab markers, not symptoms of deficiency. Ask your doctor whether this matters for you, and tell the lab before blood tests if you take high-dose biotin, because 10 mg a day distorted some hormone tests in healthy adults.
The label lists niacinamide (nicotinamide) among substances shown or expected to raise carbamazepine levels by slowing the liver enzyme CYP3A4, and asks for close monitoring of levels when they are combined. The human evidence is a 1982 report in which nicotinamide, given on purpose in the study, raised carbamazepine levels in two patients. The smaller amounts in most multivitamins have not been studied; tell your prescriber before starting a stand-alone niacinamide supplement, as they may check your level.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (6)
+ alcohol
highCarbamazepine can cause dizziness and drowsiness on its own, and alcohol can add to both. The Tegretol label advises caution with alcohol because of a possible additive sedative effect, and its Medication Guide says not to drink until you talk to your healthcare provider. The Equetro label lists alcohol among central nervous system (CNS) depressants that can raise the risk of slowed breathing, profound sedation, low blood pressure and fainting with carbamazepine. This comes from the drug labels; no human study of the pair was found, and the labels do not say alcohol changes carbamazepine blood levels.
+ st. john's wort
highBoth carbamazepine and St. John's Wort speed up CYP3A4, the liver enzyme that breaks carbamazepine down. In the only human study, 14 days of St. John's Wort did not change carbamazepine levels in 8 healthy volunteers already at a steady carbamazepine dose, likely because carbamazepine had already sped up its own breakdown. The UK medicines regulator still advises people with epilepsy not to use St. John's Wort with any anti-seizure medicine.
+ vitamin d
highLong-term carbamazepine use is linked to lower vitamin D. A meta-analysis of 12 studies found lower 25-hydroxyvitamin D in carbamazepine users than in controls, and an observational study found a pattern of bone markers suggestive of secondary hyperparathyroidism. The likely cause is faster breakdown of vitamin D by liver enzymes that carbamazepine switches on. The Tegretol label reports decreased blood calcium and osteoporosis.
+ grapefruit
highGrapefruit juice inhibits the intestinal CYP3A4 enzyme that performs first-pass metabolism of carbamazepine, allowing more of each oral dose to reach the bloodstream. A human study in epilepsy patients found grapefruit juice raised carbamazepine blood levels, which matters because carbamazepine has a narrow safety margin.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I eat grapefruit or drink grapefruit juice with carbamazepine?⌄
Talk to your doctor or pharmacist first. In a study of 10 people with epilepsy, grapefruit juice raised carbamazepine levels by about 40%, and the label lists it among things that raise levels. Too much carbamazepine can cause dizziness, drowsiness, unsteadiness or double vision.
Should I take vitamin D with carbamazepine?⌄
Ask your doctor whether to check your level. A meta-analysis of 12 studies found people on carbamazepine had lower vitamin D levels (about 22 versus 28 ng/mL), and the label lists low calcium and osteoporosis among reported effects. Your doctor can decide whether you need testing or treatment.
Is St. John's wort safe with carbamazepine?⌄
The UK medicines regulator advises people with epilepsy not to use St. John's wort with any anti-seizure medicine. A small study did not find that it changed carbamazepine levels, but the advice covers all anti-seizure drugs after a reported case of more frequent, more severe seizures. Talk to your neurologist or pharmacist before starting or stopping it.
Does carbamazepine affect birth control?⌄
Yes. The label says it can make birth control pills and hormonal implants less effective, and unintended pregnancies have been reported. Tell your prescriber if your bleeding pattern changes, and ask about a backup or alternative method.
Can I drink alcohol on carbamazepine?⌄
The Medication Guide says not to drink alcohol until you talk to your healthcare provider, because alcohol can add to carbamazepine's sleepiness and dizziness. Ask your prescriber what is safe for you.
Why do I need blood tests on carbamazepine?⌄
The label calls for blood counts before starting and liver tests during treatment, and a genetic test (HLA-B*1502) before starting in people with ancestry in at-risk Asian populations. Drug levels can help when seizures change or several medicines are used, and sodium can fall, especially in older adults.
References by claim
acute manic or mixed episodes of bipolar I disorder (Equetro)
trigeminal neuralgia and other long-term nerve pain
Wiffen et al., 2014 · PMC (2014) link
Safety
Interaction: Grapefruit and grapefruit juice
Garg et al., 1998 · PubMed (1998) link
Interaction: Vitamin D
LoPinto-Khoury et al., 2021 · PubMed (2021) link
Interaction: St. John's wort
Interaction: Biotin (vitamin B7)
Interaction: Niacinamide (nicotinamide, a form of vitamin B3)
Bourgeois et al., 1982 · PubMed (1982) link
Track Carbamazepine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
